Search

Viatris Inc

Закрыт

СекторЗдравоохранение

17.82 2.24

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

17.8

Макс.

17.96

Ключевые показатели

By Trading Economics

Доход

-295M

-119M

Продажи

240M

3.8B

Прибыль на акцию

0.69

Дивидендная доходность

2.83

Рентабельность продаж

-3.162

Сотрудники

30,000

EBITDA

9.4M

653M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+9.05% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

2.83%

2.25%

Следующий отчет о доходах

5 нояб. 2026 г.

Дата следующей выплаты дивидендов

14 дек. 2026 г.

Следующая эксдивидендная дата

23 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-890M

20B

Предыдущая цена открытия

15.58

Предыдущая цена закрытия

17.82

Новостные настроения

By Acuity

100%

0%

300 / 339 Рейтинг в Healthcare

Viatris Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

25 сент. 2026 г., 22:45 UTC

News

Viatris Inc is seeing a modest increase in after-market trading after filing a lawsuit against Novo Nordisk over its planned generic Wegovy.

24 сент. 2026 г., 20:02 UTC

Viatris Inc is trading higher, reaching a peak cumulative return and positioned above its 20-day moving average during Thursday's session.

23 сент. 2026 г., 20:07 UTC

News

Shares of Viatris Inc declined despite Oppenheimer initiating coverage with an Outperform rating and a $25 price target, amid broader market downward pressure.

22 сент. 2026 г., 22:30 UTC

Viatris Inc is declining in after-market trading, moving lower since Tuesday's close despite peaking above the previous close earlier in the session.

21 сент. 2026 г., 23:01 UTC

Viatris Inc is trading modestly higher in after-market hours, reaching a peak return since Monday's close and staying near the upper end of its one-month range.

18 сент. 2026 г., 21:01 UTC

Viatris Inc. is trading modestly higher in after-market hours, currently positioned above its 20-day moving average and near the upper end of its one-month range.

17 сент. 2026 г., 20:08 UTC

Viatris Inc. shares are up modestly, reaching a peak above the previous close while remaining above the 20-day moving average.

16 сент. 2026 г., 23:16 UTC

Viatris Inc. is trading modestly lower in after-market hours, having experienced unusual volatility after initially rising earlier in the session.

15 сент. 2026 г., 20:07 UTC

Viatris shares are roughly flat as the broader market declines amid a significant drop in the NY Empire State Manufacturing Index and rising oil prices.

14 сент. 2026 г., 20:07 UTC

Viatris Inc's shares are higher today, continuing a gradual increase since Friday's close despite an earlier pullback. No specific news was identified.

11 сент. 2026 г., 21:41 UTC

Shares of Viatris Inc. declined in after-market trading, reflecting a notable dip from earlier highs and a cumulative return of -0.36% since Friday's close.

10 сент. 2026 г., 20:07 UTC

Viatris Inc shares are lower amid a broader market decline, reflecting ongoing economic concerns. The stock has seen five consecutive daily closes lower.

9 сент. 2026 г., 19:36 UTC

News

Viatris shares are lower today despite Leerink Partners initiating coverage with an Outperform rating and a price target of $20.

8 сент. 2026 г., 19:46 UTC

Viatris Inc shares are lower today, influenced by broader market declines and rising Brent crude prices amid geopolitical tensions. No specific company news was identified.

4 сент. 2026 г., 22:14 UTC

Viatris Inc is gaining in after-market trading, rising above its 20-day moving average and reaching a session high since Friday's close.

3 сент. 2026 г., 19:56 UTC

Viatris Inc is trading lower, reflecting broader market trends. The stock reached a session low earlier, with no specific news identified for the movement.

2 сент. 2026 г., 19:46 UTC

Viatris Inc. shares are trading higher during Wednesday's session, remaining above the 20-day moving average amid rising U.S. Treasury yields.

1 сент. 2026 г., 20:09 UTC

Viatris Inc shares are higher, supported by strength in the Pharmaceuticals sub-sector. Earlier, the stock pulled back from a session high.

31 авг. 2026 г., 23:14 UTC

Shares of Viatris Inc. traded lower during after-market hours, reflecting broader market sentiment amid rising crude oil prices and geopolitical tensions.

28 авг. 2026 г., 19:51 UTC

Viatris Inc shares are trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

27 авг. 2026 г., 23:02 UTC

Shares of Viatris Inc. traded lower in after-market hours. No specific company news was identified to explain the decline.

26 авг. 2026 г., 23:01 UTC

Shares of Viatris Inc declined in after-market trading, dropping from a peak to a low following four consecutive sessions of gains. No specific news was identified.

25 авг. 2026 г., 23:01 UTC

Viatris Inc shares are lower in after-market hours, reflecting a notable decline. The broader market initially showed strength but has since reversed some gains.

24 авг. 2026 г., 19:56 UTC

Viatris Inc shares are higher today, continuing a positive trend since Friday. Broader market conditions include a significant drop in crude oil prices.

21 авг. 2026 г., 23:01 UTC

Viatris Inc shares are lower in after-market hours, continuing a decline since Friday's close, with no specific news identified to explain the movement.

20 авг. 2026 г., 20:06 UTC

Viatris Inc shares are declining amid broader market trends, remaining below their 20-day moving average. Earlier in the session, shares briefly upticked before pulling back.

19 авг. 2026 г., 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

18 авг. 2026 г., 23:01 UTC

Viatris Inc shares rose in after-market trading, recovering from session lows. This increase comes amid broader market concerns over rising U.S. Treasury yields.

17 авг. 2026 г., 23:16 UTC

Viatris Inc shares are trading higher in after-market hours, following earlier directional movement. No specific news was identified to explain the price action.

14 авг. 2026 г., 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

Сравнение c конкурентами

Изменение цены

Viatris Inc Прогноз

Целевая цена

By TipRanks

9.05% рост

Прогноз на 12 месяцев

Средняя 19.444 USD  9.05%

Максимум 25 USD

Минимум 13 USD

Основано на мнении 9 аналитиков Wall Street, спрогнозировавших целевые цены для Viatris Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

9 ratings

5

Покупка

3

Удержание

1

Продажа

Настроения

By Acuity

300 / 339Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.